What ZYN's MRTP Filing Means For You

At Nicokick, we believe in empowering adult consumers with accurate information and advocating for your right to choose better alternatives to smoking. That’s why we’re proud to share that our parent company, Haypp Group AB, has submitted a public comment supporting the FDA’s review of ZYN nicotine pouch products under the Modified Risk Tobacco Product (MRTP) pathway.

The FDA invited public comments on applications to designate ZYN nicotine pouches as Modified Risk Tobacco Products, with a public hearing scheduled for January 22, 2026. This designation is reserved for products that—based on scientific evidence—pose lower health risks compared to cigarettes and traditional US smokeless tobacco products.

Haypp Group’s comment draws on years of experience in the Scandinavian market and highlights the strong scientific record showing that nicotine pouches are a better alternative to smoking.

• Lower-Risk Choices: Nicotine pouches contain no tobacco leaf and involve no combustion, placing them at the lower end of the tobacco risk spectrum. Authorizing ZYN as a Modified Risk product would allow manufacturers to communicate these scientifically substantiated benefits directly to adult consumers.
  
  
• Accurate Information: Many adults, including healthcare professionals, still misunderstand the risks of nicotine and non-combustible products. Haypp’s comment urges the FDA to support clear, evidence-based messaging so you can make informed choices.
  
  
• Advocacy for Your Rights: By participating in the regulatory process, Nicokick and Haypp Group demonstrate our commitment to standing up for your rights as adult consumers. We believe you deserve access to better alternatives and transparent information.

• FDA Review: The FDA will consider all submitted comments, including Haypp Group’s, as it reviews the ZYN MRTP applications. This process will help shape the future of nicotine pouch regulation and public health messaging in the United States.
  
  
• Stay Informed: Rest assured, we’ll keep you updated on the outcome of the FDA’s review and any changes that may affect your access to nicotine pouch products.

Nicokick is dedicated to supporting adult harm reduction, promoting transparency, and ensuring you have access to the best information and products available. We’re proud to go to bat for your rights and will continue to do so as the regulatory landscape evolves.

Thank you for being part of our community. If you have questions at all about nicotine pouches, harm reduction, or regulatory developments in the smokeless category, our team is here to help.